Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liu's Hua'ai Huixiangdan
- Development stage
- Unknown
- Lead developer
- Liu Zhongting
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Administration
- Oral
01
Overview
Liu's Hua'ai Huixiangdan is a traditional Chinese medicine (TCM) patent formulation developed for the treatment of esophageal carcinoma. The preparation is based on the therapeutic principles of "attacking toxin with toxin," clearing heat, dissipating phlegm, and strengthening body resistance. It is a complex combination of 14 ingredients, including mineral toxins (arsenolite), animal-derived toxins (blister beetle, toad venom, snake venom, centipede, leech, scorpion tail, and gecko), and restorative herbs (ginseng, pseudostellaria root, and deglued antler). The toxic components are intended to directly kill cancer cells, while the herbal components aim to enhance the patient's immune function and overall constitution. Clinical observations cited in patent documentation indicate that the medicine can improve symptoms such as dysphagia in middle-to-late stage patients and potentially extend survival time.
- Brand names
- Liu's Hua'ai Huixiangdan
- Other names
- Traditional Chinese medicine-Liu's Hua'ai huixiangdanLiu's Hua Ai Hui Xiang Dan
02
Targets
DNAPP2A (Protein phosphatase 2A)ATP1A (Sodium/potassium-transporting ATPase)
Beyond the preview
Go deeper on Liu's Hua'ai Huixiangdan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liu's Hua'ai Huixiangdan.